Executive Summary Risuteganib in Neurological Disorder Treatment Market Size and Share Forecast CAGR Value The global Risuteganib in Neurological Disorder Treatment market size was valued at USD 2.27 billion in 2024 and is expected to reach USD 3.30 billion by 2032, at a CAGR of 4.80% during the forecast period This Risuteganib in Neurological Disorder Treatment Market Research...